Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Goal-directed Fluid Therapy During DIEP Free Flap Breast Reconstruction
NCT06080178Phase 4Terminated
- Sponsor
- AZ Maria Middelares
- Start
- Nov 2023
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by AZ Maria Middelares. Primary endpoint: Total intraoperative fluid volume at 12 hours. Started Nov 2023; status: terminated.
Beyond the preview
Go deeper on NCT06080178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06080178.